Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Recent Decrease in Acute GVHD and Increased Relapse in Children with Leukemia Receiving Unrelated Donor Bone Marrow Transplants.

Stella M. Davies, MB, BS, PhD, D. Wang, MS, T. Wang, PhD, M. Arora, MD, O. Ringden, MD, C. Anasetti, MD, S. Pavletic, MD, J. Casper, MD, M.L. MacMillan, MD, J. Sanders, MD, D. Wall, MD, N.A. Kernan, MD

Blood (2007) 110 (11): 1081.

https://doi.org/10.1182/blood.V110.11.1081.1081

Published: 2007

Journal Articles

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

H. J. Deeg, H. M. Shulman, J. E. Anderson, E. M. Bryant, T. A. Gooley, J. T. Slattery, C. Anasetti, A. Fefer, R. Storb, F. R. Appelbaum

Blood (2000) 95 (4): 1188–1194.

https://doi.org/10.1182/blood.V95.4.1188.004k38_1188_1194

Published: 2000

Journal Articles

Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

Blood (1997) 89 (8): 3055–3060.

https://doi.org/10.1182/blood.V89.8.3055

Published: 1997

Journal Articles

FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors

RA Nash, LA Pineiro, R Storb, HJ Deeg, WE Fitzsimmons, T Furlong, JA Hansen, T Gooley, RM Maher, P Martin, PA McSweeney, KM Sullivan, C Anasetti, JW Fay

Blood (1996) 88 (9): 3634–3641.

https://doi.org/10.1182/blood.V88.9.3634.bloodjournal8893634

Published: 1996

Journal Articles

Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome

WI Bensinger, CD Buckner, C Anasetti, R Clift, R Storb, T Barnett, T Chauncey, H Shulman, FR Appelbaum

Blood (1996) 88 (7): 2787–2793.

https://doi.org/10.1182/blood.V88.7.2787.bloodjournal8872787

Published: 1996

Journal Articles

Alloantigen presenting function of normal human CD34+ hematopoietic cells

D Rondelli, RG Andrews, JA Hansen, R Ryncarz, MA Faerber, C Anasetti

Blood (1996) 88 (7): 2619–2675.

https://doi.org/10.1182/blood.V88.7.2619.bloodjournal8872619

Published: 1996

Journal Articles

Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

PJ Martin, BJ Nelson, FR Appelbaum, C Anasetti, HJ Deeg, JA Hansen, GB McDonald, RA Nash, KM Sullivan, RP Witherspoon, PJ Scannon, N Friedmann, R Storb

Blood (1996) 88 (3): 824–830.

https://doi.org/10.1182/blood.V88.3.824.824

Published: 1996

Journal Articles

Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors

Blood (1996) 87 (1): 51–58.

https://doi.org/10.1182/blood.V87.1.51.51

Published: 1996

Journal Articles

Unrelated donor marrow transplantation in children

A Balduzzi, T Gooley, C Anasetti, JE Sanders, PJ Martin, EW Petersdorf, FR Appelbaum, CD Buckner, D Matthews, R Storb

Blood (1995) 86 (8): 3247–3256.

https://doi.org/10.1182/blood.V86.8.3247.3247

Published: 1995

Journal Articles

The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation

EW Petersdorf, GM Longton, C Anasetti, PJ Martin, EM Mickelson, AG Smith, JA Hansen

Blood (1995) 86 (4): 1606–1613.

https://doi.org/10.1182/blood.V86.4.1606.bloodjournal8641606

Published: 1995

Journal Articles

Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study

RA Nash, R Etzioni, R Storb, T Furlong, T Gooley, C Anasetti, FR Appelbaum, K Doney, P Martin, J Slattery

Blood (1995) 85 (12): 3746–3753.

https://doi.org/10.1182/blood.V85.12.3746.bloodjournal85123746

Published: 1995

Journal Articles

Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia

RA Clift, CD Buckner, ED Thomas, E Bryant, C Anasetti, WI Bensinger, R Bowden, HJ Deeg, KC Doney, LD Fisher

Blood (1994) 84 (12): 4368–4373.

https://doi.org/10.1182/blood.V84.12.4368.bloodjournal84124368

Published: 1994

Journal Articles

Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor

C Anasetti, JA Hansen, TA Waldmann, FR Appelbaum, J Davis, HJ Deeg, K Doney, PJ Martin, R Nash, R Storb

Blood (1994) 84 (4): 1320–1327.

https://doi.org/10.1182/blood.V84.4.1320.1320

Published: 1994

Journal Articles

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia

R Storb, R Etzioni, C Anasetti, FR Appelbaum, CD Buckner, W Bensinger, E Bryant, R Clift, HJ Deeg, K Doney

Blood (1994) 84 (3): 941–949.

https://doi.org/10.1182/blood.V84.3.941.941

Published: 1994

Journal Articles

Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors [letter]

HJ Deeg, C Anasetti, E Petersdorf, R Storb, K Doney, JA Hansen, J Sanders, KM Sullivan, FR Appelbaum

Blood (1994) 83 (11): 3417–3418.

https://doi.org/10.1182/blood.V83.11.3417.3417

Published: 1994

Journal Articles

Unrelated donor or autologous marrow transplantation for treatment of acute leukemia

A Busca, C Anasetti, G Anderson, FR Appelbaum, CD Buckner, K Doney, PJ Martin, E Petersdorf, JE Sanders, JA Hansen

Blood (1994) 83 (10): 3077–3084.

https://doi.org/10.1182/blood.V83.10.3077.3077

Published: 1994

Journal Articles

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

R Storb, W Leisenring, HJ Deeg, C Anasetti, F Appelbaum, W Bensinger, CD Buckner, R Clift, K Doney, J Hansen

Blood (1994) 83 (9): 2749–2750.

https://doi.org/10.1182/blood.V83.9.2749.2749

Published: 1994

Journal Articles

Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome

JE Anderson, FR Appelbaum, LD Fisher, G Schoch, H Shulman, C Anasetti, WI Bensinger, E Bryant, CD Buckner, K Doney

Blood (1993) 82 (2): 677–681.

https://doi.org/10.1182/blood.V82.2.677.677

Published: 1993

Journal Articles

The role of HLA-DPB1 disparity in the development of acute graft-versus- host disease following unrelated donor marrow transplantation

EW Petersdorf, AG Smith, EM Mickelson, GM Longton, C Anasetti, SY Choo, PJ Martin, JA Hansen

Blood (1993) 81 (7): 1923–1932.

https://doi.org/10.1182/blood.V81.7.1923.1923

Published: 1993

Journal Articles

Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation [letter]

J Nemunaitis, C Anasetti, CD Buckner, FR Appelbaum, K Shannon-Dorcy, J Hansen, JW Singer

Blood (1993) 81 (3): 865.

https://doi.org/10.1182/blood.V81.3.865.865

Published: 1993

NARROW

Recent Decrease in Acute GVHD and Increased Relapse in Children with Leukemia Receiving Unrelated Donor Bone Marrow Transplants.

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors

Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome

Alloantigen presenting function of normal human CD34+ hematopoietic cells

Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors

Unrelated donor marrow transplantation in children

The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation

Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study

Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia

Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia

Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors [letter]

Unrelated donor or autologous marrow transplantation for treatment of acute leukemia

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome

The role of HLA-DPB1 disparity in the development of acute graft-versus- host disease following unrelated donor marrow transplantation

Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation [letter]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only